Feb 2023 $27 M No. 13 $10 to $50 million 4
CardioFocus, Inc.: Raise no. 13, Feb 2023 × Investors in this round 4 investors had bought by the notice of Feb 24, 2023: 4 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $27 M of $32 M offered; $5 M still to sell
Smallest investment taken no minimum stated
What was sold equity, debt Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice Scott Fletcher · Executive Officer Stephan Ogilvie · Executive Officer Bruce Robertson · Director Charles Larsen · Director David Kho · Director Gwen Watanabe · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by Scott Fletcher, Vice President of Finance & Administration. Source: SEC Form D, newest notice filed Feb 24, 2023. Read the notice at the SEC .
equity, debt SEC Mar 2022 $4 M No. 12 $2 to $10 million 12
CardioFocus, Inc.: Raise no. 12, Mar 2022 × Investors in this round 12 investors had bought by the notice of Apr 12, 2022: 12 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $4 M of $50 M offered; $46 M still to sell
Smallest investment taken no minimum stated
What was sold equity Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice Burke Barrett · Executive Officer, Director Stephan Ogilvie · Executive Officer Bruce Robertson · Director Charles Larsen · Director Omar Amirana · Director Patrick Wethington · Director Paul LaViolette · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by Burke Barrett, CEO & President. Source: SEC Form D, newest notice filed Apr 12, 2022. Read the notice at the SEC .
equity SEC Jul 2020 $12 M No. 11 $10 to $50 million 13
CardioFocus, Inc.: Raise no. 11, Jul 2020 × Investors in this round 13 investors had bought by the notice of Jul 20, 2020: 13 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $12 M of $15 M offered; $3 M still to sell
Smallest investment taken $10,000
What was sold equity Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice Burke Barrett · Executive Officer, Director Bruce Robertson · Director Charles Larsen · Director Omar Amirana · Director Patrick Wethington · Director Paul LaViolette · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by Burke Barrett, CEO & President. Source: SEC Form D, newest notice filed Jul 20, 2020. Read the notice at the SEC .
equity SEC May 2019 $8 M No. 10 $2 to $10 million 17
CardioFocus, Inc.: Raise no. 10, May 2019 × Investors in this round 17 investors had bought by the notice of May 20, 2019: 17 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $8 M of $12 M offered; $4 M still to sell
Smallest investment taken no minimum stated
What was sold equity, options or other rights to buy securities, securities to be acquired by exercising them Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice Burke C. Barrett · Executive Officer Omari C. Bouknight · Executive Officer Bruce C. Robertson · Director Charles E. Larsen · Director Christopher A. Kroeger · Director Greg C. Madden · Director Omar C. Amirana · Director Patrick C. Wethington · Director Paul C. Laviolette · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by Scott Fletcher, Vp finance & admin. Source: SEC Form D, newest notice filed May 20, 2019. Read the notice at the SEC .
equity, options SEC Apr 2018 $13 M No. 9 $10 to $50 million 1
CardioFocus, Inc.: Raise no. 9, Apr 2018 × Investors in this round 1 investor had bought by the notice of Apr 18, 2018: 1 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $13 M of $21 M offered; $8 M still to sell
Smallest investment taken no minimum stated
What was sold debt, options or other rights to buy securities, securities to be acquired by exercising them Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions $2,600,000
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice Burke R. Barrett · Executive Officer Paul C. Laviolette · Executive Officer, Director Warren R. Clark, Iii · Executive Officer Bruce C. Robertson · Director Charles E. Larsen · Director Christopher A. Kroeger · Director Greg R. Madden · Director Omar C. Amirana · Director Patrick R. Wethington · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round TRUMP SECURITIES LLC (CRD 47107) · New York, New York Sold in NY Signed by Warren R. Clark, Iii, Cfo. Source: SEC Form D and 1 amendment, newest notice filed Apr 18, 2018. Read the notice at the SEC .
debt, options SEC Feb 2017 $20 M No. 8 $10 to $50 million 26
CardioFocus, Inc.: Raise no. 8, Feb 2017 × Investors in this round 26 investors had bought by the notice of Mar 1, 2017: 26 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $20 M of $32 M offered; $12 M still to sell
Smallest investment taken no minimum stated
What was sold equity, options or other rights to buy securities Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice Burke J. Barrett · Executive Officer Paul C. Laviolette · Executive Officer, Director Warren C. Clark, Iii · Executive Officer Bruce C. Robertson · Director Charles Larsen · Director Christopher Kroeger · Director James Garvey · Director Omar C. Amirana · Director Patrick J. Wethington · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by Warren Clark, Iii, Cfo. Source: SEC Form D, newest notice filed Mar 1, 2017. Read the notice at the SEC .
equity, options SEC May 2016 $8 M No. 7 $2 to $10 million 0
CardioFocus, Inc.: Raise no. 7, May 2016 × Investors in this round 0 investors had bought by the notice of May 18, 2016: 0 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $8 M of $12 M offered; $4 M still to sell
Smallest investment taken no minimum stated
What was sold equity, debt, other: CONVERTIBLE DEBT Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice Warren R. Clark, Iii · Executive Officer Bruce C. Robertson · Director Charles E. Larsen · Director Christopher A. Kroeger · Director James E. Garvey · Director Omar C. Anirana · Director Paul C. Laviolette · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by Warren R. Clark, Iii, Cfo. Source: SEC Form D, newest notice filed May 18, 2016. Read the notice at the SEC .
equity, debt SEC Dec 2014 $32 M No. 6 $10 to $50 million 32
CardioFocus, Inc.: Raise no. 6, Dec 2014 × Investors in this round 32 investors had bought by the notice of Jan 6, 2015: 32 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $32 M of $33 M offered; $2 M still to sell
Smallest investment taken no minimum stated
What was sold equity, other: Preferred Stock can convert to Common Stock. Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice Anjie Roldan · Executive Officer Lauren Jennings · Executive Officer Paul LaViolette · Executive Officer, Director Stephen Sagon · Executive Officer, Director Warren Clark · Executive Officer Bruce Robertson · Director Charles Larsen · Director Christopher Kroeger · Director James Garvey · Director Omar Amirana · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Remarks in the notice On the amounts: “A portion of the proceeds were satisfied through conversion of Promissory Notes.”Signed by Stephen Sagon, President. Source: SEC Form D, newest notice filed Jan 6, 2015. Read the notice at the SEC .
equity SEC Nov 2014 $2 M No. 5 $2 to $10 million 29
CardioFocus, Inc.: Raise no. 5, Nov 2014 × Investors in this round 29 investors had bought by the notice of Nov 13, 2014: 29 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $2 M of $2 M offered
Smallest investment taken no minimum stated
What was sold equity, debt, other: Convertible debt Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice Stephen W Sagon · Executive Officer, Director Warren R Clark III · Executive Officer Bruce C Robertson · Director Charles E Larsen · Director Christopher A Kroeger · Director James E Garvey · Director Omar R Amirana · Director Paul C LaViolette · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by Stephen W. Sagon, President. Source: SEC Form D, newest notice filed Nov 13, 2014. Read the notice at the SEC .
equity, debt SEC Apr 2014 $2 M No. 4 $2 to $10 million 27
CardioFocus, Inc.: Raise no. 4, Apr 2014 × Investors in this round 27 investors had bought by the notice of May 9, 2014: 27 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $2 M of $5 M offered; $3 M still to sell
Smallest investment taken no minimum stated
What was sold equity, debt, other: Convertible Debt Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice David R. Kressler · Executive Officer · Director of Medical Devices Paul W. Laviolette · Executive Officer, Director Stephen W. Sagon · Executive Officer, Director Warren R. Clark III · Executive Officer Bruce W. Robertson · Director Charles W. Larson · Director Christopher A. Kroeger · Director James W. Garvey · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by Stephen W. Sagon, President. Source: SEC Form D, newest notice filed May 9, 2014. Read the notice at the SEC .
equity, debt SEC Feb 2011 $14 M No. 3 $10 to $50 million 25
CardioFocus, Inc.: Raise no. 3, Feb 2011 × Investors in this round 25 investors had bought by the notice of Feb 24, 2011: 25 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $14 M of $16 M offered; $2 M still to sell
Smallest investment taken $2,000
What was sold equity
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice Stephen W. Sagon · Executive Officer, Director Bruce A. Robertson · Director Charles A. Larsen · Director Christopher A. Kroeger · Director James A. Garvey · Director Omar A. Amirana · Director Paul A. LaViolette · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by Stephen W. Sagon, President. Source: SEC Form D, newest notice filed Feb 24, 2011. Read the notice at the SEC .
equity SEC Apr 2010 $5 M No. 2 $2 to $10 million 13
CardioFocus, Inc.: Raise no. 2, Apr 2010 × Investors in this round 13 investors had bought by the notice of Apr 20, 2010: 13 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $5 M of $5 M offered
Smallest investment taken $5,000
What was sold equity, debt, options or other rights to buy securities
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice Stephen Sagon · Executive Officer, Director Bruce Robertson · Director Charles Larsen · Director Christopher Kroeger · Director James Garvey · Director John Schulte · Director Marlene Krauss · Director Omar Amirana · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by Lauren Jennings, Secretary. Source: SEC Form D, newest notice filed Apr 20, 2010. Read the notice at the SEC .
equity, debt, options SEC Jun 2009 $6 M No. 1 $2 to $10 million 19
CardioFocus, Inc.: Raise no. 1, Jun 2009 × Investors in this round 19 investors had bought by the notice of Jun 25, 2009: 19 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $6 M of $9 M offered; $3 M still to sell
Smallest investment taken $5,000
What was sold debt, options or other rights to buy securities
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
Estimates the notice marks payments to its own people as estimates
The company Corporation, incorporated in Delaware People named in the notice Stephen Sagon · Executive Officer, Director Bruce C. Robertson · Director Charles E. Larsen · Director Christopher A. Kroeger · Director James Garvey · Director John Schulte · Director Marlene Krauss · Director Omar Amirana · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by Lauren Jennings, Secretary. Source: SEC Form D, newest notice filed Jun 25, 2009. Read the notice at the SEC .
debt, options SEC